Trials / Sponsors / Centocor Research & Development, Inc.
Centocor Research & Development, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participant Prostate Cancer | Phase 2 | 2009-09-01 |
| Completed | A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Syst Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Systemic | Phase 1 | 2007-03-01 |
| Completed | A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis | Phase 3 | 2005-12-01 |
| Completed | A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis Psoriasis | Phase 3 | 2005-05-01 |